Chengdu Shengdi

Chengdu Shengdi Pharmaceutical is a prominent subsidiary of Jiangsu Hengrui Pharmaceuticals, located in the Chengdu Medical City in Sichuan, China. Established as a core strategic hub, the company integrates high-end research and development with large-scale manufacturing capabilities for both innovative small molecules and biologics. Its operations focus on critical therapeutic areas such as oncology, metabolic diseases, and autoimmune disorders. The facility features state-of-the-art production lines that adhere to international Good Manufacturing Practice (GMP) standards, supporting the global commercialization of Hengrui's pipeline. Chengdu Shengdi is instrumental in advancing novel therapies through clinical stages to market, significantly contributing to the parent company's status as a leader in the Chinese pharmaceutical industry.